Biocatalysts & Enzyme Engineering Market Research Report: Information by Product Type (Enzymes, Co- Enzyme), By Application (Pharmaceutical Manufacturing, Synthetic Biology and Metabolic Engineering, Diagnostic, others), By End User (Pharmaceutical and Biopharmaceutical Companies, CROs and CDMOs, Diagnostics and Clinical Laboratories, Others), By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) -Global Forecast to 2035.
As per MRFR analysis, Biocatalysts & Enzyme Engineering Market Application was valued at USD 3,038.9 million in 2024. The Biocatalysts & Enzyme Engineering Industry is projected to grow from USD 3,217.59 million in 2025 to USD 5,631.9 million by 2035, exhibiting a compound annual growth rate (CAGR) of 5.88% during the forecast period (2025 - 2035).
The Biocatalysts & Enzyme Engineering Market is being reshaped by a convergence of technological, regulatory, and sustainability trends, pushing biocatalysis from a niche “green add on” to a core pillar of industrial process design.
| 2024 Market Size | 3,038.9 (USD Million) |
| 2035 Market Size | 5,631.9 (USD Million) |
| CAGR (2025 - 2035) | 5.88% |
Amano Enzyme Inc., Infinita Biotech, Advanced Enzyme Technologies Ltd., Novozymes A/S, Codexis, Inc., Biocatalysts Ltd, Creative Enzymes, Asymchem Laboratories Group, Almac Group, EnginZyme.
Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry
Working together with universities is a big opportunity for growth and for driving innovation in the area of biocatalysts and numerous products and markets developed using enzymatic processes and biocatalysts. The major drivers of discovery and development of enzymes, synthetic biology, and gene modification are the academic institutions and research laboratories.
The collaboration with these institutions will enable companies to gain access to some of the most advanced research and development done in the area of enzyme and biocatalyst development, laboratory facilities, and expert knowledge without incurring the full costs of their internal research and development. Through partnerships with universities, companies can expedite the development of novel enzymes, and a shortage of trained professionals in some regions act as restraints, moderating market expansion.
Market expansion is being driven mainly by the pharmaceutical and biopharmaceutical industries. Use of biocatalysts will be seen in producing drugs and is very useful in developing complicated molecules because of the accuracy to produce very specific molecules as well as having high levels of purity. As with modern medications, high levels of accuracy pertaining to the manufacture of the medications will be crucial since precision equates to safety and effectiveness. Manufacturing enzymes reduces the number of required reaction steps for manufacturing to be more efficient, ultimately leading to increased output from each batch made. Therefore, both costs related to drug production and the schedule related to getting the drug onto the market can be reduced, which are critically important due to the highly competitive and regulated pharmaceutical manufacturing environment. Furthermore, there is an increase in the global prevalence of chronic illnesses as well as a growing aging population that is going to continue to generate a high demand for pharmaceuticals. Thus, the pressure is being placed on pharmaceutical manufacturers to be as efficient as possible in the manufacture of drugs at a lower cost which will ultimately accelerate the adoption of enzyme-based solutions for developing drug products.
Based on Product type, the Biocatalysts & Enzyme Engineering Market has been segmented into Enzymes, Co- Enzyme. The enzymes demonstrate their function as biological catalysts through their protein composition because they speed up chemical reactions without exhausting their catalytic capacity. Co-enzymes serve as essential compounds because they consist of tiny organic molecules which do not contain protein and function as enzyme partners that enable chemical reactions to occur.
Based on Application, the Biocatalysts & Enzyme Engineering Market has been segmented into Pharmaceutical Manufacturing, Synthetic Biology and Metabolic Engineering, Diagnostic, others. The production of active pharmaceutical ingredients and their intermediates require enzymes which provide precise chemical transformation capabilities. Synthetic biology and metabolic engineering create a new field which biocatalysts and enzyme engineering technologies can be used for.
Based on End Users, the Biocatalysts & Enzyme Engineering Market has been segmented into Pharmaceutical and Biopharmaceutical Companies, CROs and CDMOs, Diagnostics and Clinical Laboratories, Others. The main customers who need biocatalysts and enzyme engineering solutions are pharmaceutical and biopharmaceutical companies. The biocatalysts market is seeing Contract Research Organizations and Contract Development and Manufacturing Organizations emerge as major customer groups.
Get more detailed insights about Biocatalysts and Enzyme Engineering Market Request Free Sample
The North American market for biocatalysts and enzyme engineering shows advanced development because pharmaceutical companies and biotechnology firms and industrial businesses operate there. The region benefits from a well-established life sciences ecosystem which includes advanced research and development facilities and a highly skilled workforce and substantial biotechnology funding. The United States stands as the primary force in the region while Canada follows behind because both nations possess strong expertise in enzyme engineering and synthetic biology and large-scale biomanufacturing. The presence of leading pharmaceutical companies and biotech firms and specialized enzyme manufacturers establishes North America as a crucial center for the worldwide market.
The market for biocatalysts and enzyme engineering in Europe shows mature development but maintains strong capacity for innovative research through its established regulatory system and advanced research facilities and established industrial system. The region has numerous top enzyme producers and biotechnology companies and pharmaceutical businesses which operate from Germany and France and the United Kingdom and Denmark and Switzerland. Europe functions as a leading force which drives worldwide acceptance of biocatalysis technologies through its dedication to sustainable practices and circular economy methods and green industrial development.
The Asia Pacific market demonstrates strong growth because of its increasing demand for pharmaceutical and biopharmaceutical manufacturing. The active pharmaceutical ingredient (API) production and contract manufacturing services have established the region as the global center for these operations. Companies today use biocatalysis to make their processes more efficient while reducing expenses and achieving international standards for quality and environmental performance. Enzyme-based processes become common in drug production as countries like India and China transition to environmentally friendly methods of manufacturing.
South America functions as an emerging market which experiences industrial growth through pharmaceutical manufacturing expansion and sustainable technology development. Key countries such as Brazil, Mexico, and Argentina are driving regional growth, supported by improving healthcare infrastructure, rising investments in biotechnology, and a strong agricultural base. The region has developed resources which enable industrial expansion to occur after North America and Europe, but it still has less developed markets than those two regions. The pharmaceutical and generic drug manufacturing sector drives market expansion throughout South America. Brazil and Mexico are building their domestic production capabilities while they adopt biocatalysis technology for operational efficiency and international product standards compliance. Companies that provide contract manufacturing services and research organizations are driving the adoption of enzyme-based processes because these systems help organizations create cost-effective solutions which can be expanded to full-scale operations.
The Middle East & Africa (MEA) region represents a nascent but steadily evolving market for biocatalysts and enzyme engineering, characterized by gradual industrial diversification and increasing focus on biotechnology adoption. The region comprises key markets such as the Gulf Cooperation Council (GCC) countries, South Africa, and parts of North and East Africa. While the overall market size remains relatively smaller compared to other regions, MEA is witnessing growing interest in enzyme-based solutions driven by economic diversification strategies, particularly in the Middle East, and improving industrial capabilities across Africa.
Many global, regional, and local vendors characterize the Biocatalysts & Enzyme Engineering Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in Product, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations. Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market. The major players in the market Include Amano Enzyme Inc., Infinita Biotech, Advanced Enzyme Technologies Ltd., Novozymes A/S, Codexis, Inc., Biocatalysts Ltd, Creative Enzymes, Asymchem Laboratories Group, Almac Group, EnginZyme, strategic market developments and decisions to improve operational effectiveness.
March 2026: Codexis, Inc. a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced it has entered into an agreement with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA (siRNA) using its proprietary ECO Synthesis manufacturing platform to support preclinical development of a therapeutic candidate targeting a cardiovascular indication.
September 2025: Asymchem, a leading global CDMO service provider, announced a strategic investment in Snapdragon Chemistry, a private U.S. chemical technology company focused on the design and development of efficient and sustainable manufacturing processes for pharmaceutical applications. Asymchem led the investment round, along with the participation from Snapdragon’s previous investors. The funding provides capital for Snapdragon to complete its expansion plan to build cGMP drug substance manufacturing suites.
March 2026: Almac Sciences, a member of the Almac Group, is pleased to announce a significant expansion of its API and flow chemistry services with the launch of cGMP compliant flow high pressure hydrogenation. This new capability brings enhanced precision, safety, and scalability to one of the most critical transformations in modern synthetic chemistry and is now available for both clinical and commercial manufacturing programs.
The Biocatalysts & Enzyme Engineering Market is projected to grow at a 5.88% CAGR from 2025 to 2035, driven by increasing demand for high-performance computing and enhanced security features.
New opportunities lie in:
|
Market Application 2024 |
3,038.9 (USD Million) |
|
Market Application 2025 |
3,217.59 (USD Million) |
|
Market Application 2035 |
5,631.9 (USD Million) |
|
Compound Annual Growth Rate (CAGR) |
5.88% (2025 - 2035) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Base Year |
2024 |
|
Market Forecast Period |
2025 - 2035 |
|
Historical Data |
2019 - 2023 |
|
Market Forecast Units |
USD Million |
|
Key Companies Profiled |
Amano Enzyme Inc., Infinita Biotech, Advanced Enzyme Technologies Ltd., Novozymes A/S, Codexis, Inc., Biocatalysts Ltd, Creative Enzymes, Asymchem Laboratories Group, Almac Group, EnginZyme. |
|
Segments Covered |
By Product Type By Application By End User |
|
Key Market Opportunities |
Expansion into Emerging Markets Partnerships with Academic Institutions. |
|
Key Market Dynamics |
Increasing Demand for Green Technologies Rising Healthcare Costs. |
|
Region Covered |
North America, Europe, Asia Pacific, South America, Middle East & Africa. |
Kindly complete the form below to receive a free sample of this Report
“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”
“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”
“Thanks for sending the report it gives us a good global view of the Betaïne market.”
“Thank you, this will be very helpful for OQS.”
“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”
“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”
“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”
